PCNA and neoplasm: Our findings from pan-cancer analysis supportthe hypothesis that PCNA’s expression (mRNA) across diversecancers could be harnessed for broad-spectrum cancer diagnostics.Furthermore, variable expression can be attributed to genetic mutations,post-translational modifications, epigenetic changes, altered signalingnetworks, and the tumor microenvironment, which may contribute tocancer development and survival.